Table 1.

Characteristics of the Mothers (n = 170) at Inclusion and the Modes of Conception, Pregnancy Complications, and Placenta Weight in the Pregnancies (n = 182a)

nMetforminbnPlacebob
At baseline
 Age, y8729.5 ± 3.78329.7 ± 4.2
 Height, cm87167.1 ± 5.383167.6 ± 5.1
 Weight, kg8781.3 ± 20.38379.6 ± 18.4
 BMI, kg/m28729.1 ± 7.08328.4 ± 6.5
 Systolic blood pressure, mm Hg87118 ± 1383117 ± 12
 Diastolic blood pressure, mm Hg8773 ± 108372 ± 10
 Pulse, bpm7674 ± 107274 ± 9
 OGTT (75 g)
  Fasting plasma glucose, mmol/L784.5 ± 0.5764.7 ± 0.6
  2-h plasma glucose, mmol/L785.4 ± 1.5755.4 ± 1.6
 Smoking, %873 (3.4)836 (7.2)
 Parity8783
  Nullipara, %53 (60.9)48 (57.8)
  Multipara, %34 (39.1)35 (43.2)
 PCOS phenotype
  National Institutes of Health criteria, %7848 (61.5)7646 (60.5)
  Fulfills only Rotterdam criteria, %7830 (38.5)7630 (39.5)
Mode of conception9290
 Spontaneously, %52 (56.5)52 (57.8)
 Ovulation induction, %25 (27.2)14 (15.6)
 IVF/ICSI, %15 (16.3)21 (23.3)
 Other, %0 (0)3 (3.3)
Weight gain in pregnancy, kg909.1 ± 5.58910.2 ± 5.2
Pregnancy complications9290
 Preterm birth, %2 (2.2)7 (7.8)
 GDMc, %21 (22.8)29 (32.2)
 Preeclampsia, %14 (15.2)12 (13.3)
Placenta weight, g82649 ± 16077673 ± 162
Breastfeeding
 Duration of breastfeeding, mo709.5 ± 4.1659.0 ± 3.7
 Duration of exclusive breastfeeding, mo684.6 ± 2.8624.2 ± 2.9
nMetforminbnPlacebob
At baseline
 Age, y8729.5 ± 3.78329.7 ± 4.2
 Height, cm87167.1 ± 5.383167.6 ± 5.1
 Weight, kg8781.3 ± 20.38379.6 ± 18.4
 BMI, kg/m28729.1 ± 7.08328.4 ± 6.5
 Systolic blood pressure, mm Hg87118 ± 1383117 ± 12
 Diastolic blood pressure, mm Hg8773 ± 108372 ± 10
 Pulse, bpm7674 ± 107274 ± 9
 OGTT (75 g)
  Fasting plasma glucose, mmol/L784.5 ± 0.5764.7 ± 0.6
  2-h plasma glucose, mmol/L785.4 ± 1.5755.4 ± 1.6
 Smoking, %873 (3.4)836 (7.2)
 Parity8783
  Nullipara, %53 (60.9)48 (57.8)
  Multipara, %34 (39.1)35 (43.2)
 PCOS phenotype
  National Institutes of Health criteria, %7848 (61.5)7646 (60.5)
  Fulfills only Rotterdam criteria, %7830 (38.5)7630 (39.5)
Mode of conception9290
 Spontaneously, %52 (56.5)52 (57.8)
 Ovulation induction, %25 (27.2)14 (15.6)
 IVF/ICSI, %15 (16.3)21 (23.3)
 Other, %0 (0)3 (3.3)
Weight gain in pregnancy, kg909.1 ± 5.58910.2 ± 5.2
Pregnancy complications9290
 Preterm birth, %2 (2.2)7 (7.8)
 GDMc, %21 (22.8)29 (32.2)
 Preeclampsia, %14 (15.2)12 (13.3)
Placenta weight, g82649 ± 16077673 ± 162
Breastfeeding
 Duration of breastfeeding, mo709.5 ± 4.1659.0 ± 3.7
 Duration of exclusive breastfeeding, mo684.6 ± 2.8624.2 ± 2.9

None of the comparisons between the groups showed statistical significant difference (P < 0.05).

Abbreviations: GDM, gestational diabetes mellitus; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; OGTT, oral glucose tolerance test.

a

Twelve mothers participated twice.

b

Data presented as mean ± standard deviation or n (%) as appropriate.

c

Gestational diabetes mellitus defined as fasting plasma glucose higher than 7.0 mmol/L and/or 2-hour serum glucose higher than 7.8 mmol/L after a 75-g oral glucose tolerance test.

Table 1.

Characteristics of the Mothers (n = 170) at Inclusion and the Modes of Conception, Pregnancy Complications, and Placenta Weight in the Pregnancies (n = 182a)

nMetforminbnPlacebob
At baseline
 Age, y8729.5 ± 3.78329.7 ± 4.2
 Height, cm87167.1 ± 5.383167.6 ± 5.1
 Weight, kg8781.3 ± 20.38379.6 ± 18.4
 BMI, kg/m28729.1 ± 7.08328.4 ± 6.5
 Systolic blood pressure, mm Hg87118 ± 1383117 ± 12
 Diastolic blood pressure, mm Hg8773 ± 108372 ± 10
 Pulse, bpm7674 ± 107274 ± 9
 OGTT (75 g)
  Fasting plasma glucose, mmol/L784.5 ± 0.5764.7 ± 0.6
  2-h plasma glucose, mmol/L785.4 ± 1.5755.4 ± 1.6
 Smoking, %873 (3.4)836 (7.2)
 Parity8783
  Nullipara, %53 (60.9)48 (57.8)
  Multipara, %34 (39.1)35 (43.2)
 PCOS phenotype
  National Institutes of Health criteria, %7848 (61.5)7646 (60.5)
  Fulfills only Rotterdam criteria, %7830 (38.5)7630 (39.5)
Mode of conception9290
 Spontaneously, %52 (56.5)52 (57.8)
 Ovulation induction, %25 (27.2)14 (15.6)
 IVF/ICSI, %15 (16.3)21 (23.3)
 Other, %0 (0)3 (3.3)
Weight gain in pregnancy, kg909.1 ± 5.58910.2 ± 5.2
Pregnancy complications9290
 Preterm birth, %2 (2.2)7 (7.8)
 GDMc, %21 (22.8)29 (32.2)
 Preeclampsia, %14 (15.2)12 (13.3)
Placenta weight, g82649 ± 16077673 ± 162
Breastfeeding
 Duration of breastfeeding, mo709.5 ± 4.1659.0 ± 3.7
 Duration of exclusive breastfeeding, mo684.6 ± 2.8624.2 ± 2.9
nMetforminbnPlacebob
At baseline
 Age, y8729.5 ± 3.78329.7 ± 4.2
 Height, cm87167.1 ± 5.383167.6 ± 5.1
 Weight, kg8781.3 ± 20.38379.6 ± 18.4
 BMI, kg/m28729.1 ± 7.08328.4 ± 6.5
 Systolic blood pressure, mm Hg87118 ± 1383117 ± 12
 Diastolic blood pressure, mm Hg8773 ± 108372 ± 10
 Pulse, bpm7674 ± 107274 ± 9
 OGTT (75 g)
  Fasting plasma glucose, mmol/L784.5 ± 0.5764.7 ± 0.6
  2-h plasma glucose, mmol/L785.4 ± 1.5755.4 ± 1.6
 Smoking, %873 (3.4)836 (7.2)
 Parity8783
  Nullipara, %53 (60.9)48 (57.8)
  Multipara, %34 (39.1)35 (43.2)
 PCOS phenotype
  National Institutes of Health criteria, %7848 (61.5)7646 (60.5)
  Fulfills only Rotterdam criteria, %7830 (38.5)7630 (39.5)
Mode of conception9290
 Spontaneously, %52 (56.5)52 (57.8)
 Ovulation induction, %25 (27.2)14 (15.6)
 IVF/ICSI, %15 (16.3)21 (23.3)
 Other, %0 (0)3 (3.3)
Weight gain in pregnancy, kg909.1 ± 5.58910.2 ± 5.2
Pregnancy complications9290
 Preterm birth, %2 (2.2)7 (7.8)
 GDMc, %21 (22.8)29 (32.2)
 Preeclampsia, %14 (15.2)12 (13.3)
Placenta weight, g82649 ± 16077673 ± 162
Breastfeeding
 Duration of breastfeeding, mo709.5 ± 4.1659.0 ± 3.7
 Duration of exclusive breastfeeding, mo684.6 ± 2.8624.2 ± 2.9

None of the comparisons between the groups showed statistical significant difference (P < 0.05).

Abbreviations: GDM, gestational diabetes mellitus; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; OGTT, oral glucose tolerance test.

a

Twelve mothers participated twice.

b

Data presented as mean ± standard deviation or n (%) as appropriate.

c

Gestational diabetes mellitus defined as fasting plasma glucose higher than 7.0 mmol/L and/or 2-hour serum glucose higher than 7.8 mmol/L after a 75-g oral glucose tolerance test.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close